Abstract

INTRODUCTION: Benefits of Enhanced Recovery After Surgery (ERAS) protocols are well-established for the general surgical population, but there is limited studies specifically evaluating the efficacy in obese patients. We implemented an ERAS protocol among gynecologic oncology patients undergoing laparotomy and assessed outcomes in obese (≥30) vs non-obese. METHODS: The gynecologic oncology department implemented an ERAS protocol as a quality improvement initiative in patients undergoing laparotomy. Data was prospectively collected on patients where ERAS was implemented and compared to historical controls (pre-ERAS). A descriptive analysis on outcomes was assessed by comparing obese (BMI>30) and non-obese patients. RESULTS: The average length of stay (LOS) in ERAS vs pre-ERAS is 3.5 days vs 4.7 days (P=.002). Non-obese ERAS vs pre–ERAS LOS 3.2 days vs 4.6 days (P=.05). However, obese patients tend to have longer LOS, 3.2 days vs 3.8 days (NS). Although PO analgesics were used per ERAS protocol, obese patients used patient-controlled analgesia (PCA) more often than non-obese patients (13% vs 3%). The rate of complications (9-15%) and readmissions (0-5%) was similar among all groups. CONCLUSION: ERAS is effective, but there is a trend towards increased LOS and PCA usage in obese patients; though there is no difference in post-op complications and readmissions. Further investigation is needed to determine how obesity affects recovery after surgery.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.